Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus in moderate to severe keratoconjunctivitis sicca
NCT00128245Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2004
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pimecrolimus in keratoconjunctivitis sicca (KCS), sponsored by Novartis. Started Sep 2004; status: completed.
02
Drugs
pimecrolimus
03
Conditions
keratoconjunctivitis sicca (KCS)
Beyond the preview
Go deeper on NCT00128245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128245.